Skip to content

Methodological Evaluation of Gingival Crevicular Fluid Volume and Elastase Level

Methodological Evaluation of Gingival Crevicular Fluid Volume and Elastase Levels: Sequential Sampling, Length of Sampling Time And Two Different Sampling Methods

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02676362
Enrollment
20
Registered
2016-02-08
Start date
2008-03-31
Completion date
2008-12-31
Last updated
2016-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis

Brief summary

The mechanisms underlying the formation and composition of gingival crevicular fluid (GCF) and its flow into and from periodontal pockets are not understood very well. The aim of this study was to evaluate the length of sampling time and sequential sampling of GCF neutrophil elastase (NE) enzyme activity by using intracrevicular and orifice methods.

Detailed description

Twenty adults (mean age of 41.8 years. ranged 31-60 years. 18 males. 2 females) with chronic periodontitis were enrolled and all completed the 3-day study. Three-hundred-sixty samples of GCF were harvested from the interproximal sites of each of the two maxillary non-molar teeth according to the orifice method. Each site was sampled three times with 1-min intervals between repeat samples. By using intracrevicular method, the other 360 samples of GCF were collected on the same sites following 10-minutes interval. In first day, 2nd day and 3rd day the length of sampling time in seconds and order were 5. 10. 30; 10. 30. 5 and 30. 5. 10. respectively. GCF elastase activity was determined by hydrolysis of neutrophil specific substrate N-methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroanilide and was expressed as concentration (microU/microl) and total enzyme activity (microU).

Interventions

OTHERGingival crevicular fluid collection with filter paper

Gingival Crevicular Fluid Dynamics

Sponsors

Baskent University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
31 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* no history of systemic disease; * no history of antibiotics and/or anti-inflammatory drugs within the past 6 months; * no received any oral hygiene prophylaxis and scaling and root planing within the past 6 months; * at least 2 interproximal sites exhibiting higher than 5 mm probing depth, radiographic bone loss and gingival index of 2 (with preference of two maxillary non-molar teeth)

Exclusion criteria

* with metabolic diseases * pregnancy, lactation etc.

Design outcomes

Primary

MeasureTime frame
The length of sampling time of GCF Elastase Levels3 days

Secondary

MeasureTime frame
The length of sampling time of GCF Volume3 days
The length of sequential sampling of GCF Volume3 days
The length of sequential sampling of GCF Elastase Levels3 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026